1 |
Dick J, Schoeman JH, Mohammed A, Lom-bard C. Tuberculosis in the community: 1.Evaluation of a volunteer health worker pro-gramme to enhance adherence to anti-tuber-culosis treatment. Tubercle Lung Dis 1996;77:247-9
|
2 |
Crofton J, Chaulet P, Maher D. Guidelines for the management of drug-resistance tube-rculosis. WHO/TB/96.210. Geneva: WHO, 1997
|
3 |
Enarson DA, Rieder HL, Arnadottir T. Tuber-culosis guide for low income countries. 3rd ed. Paris: International Union Against Tuber-culosis and Lung Disease, 1994
|
4 |
World Health Organization. What is DOTS? A Guide to Understanding the WHO-recom-mended TB Control Strategy Known as DOTS. WHO/CDS/ CPC/TB/99.270. 1999
|
5 |
World Health Organization. Tuberculosis Programme. Framework for effective tuber-culosis control. WHO/TB/94.179. 1994
|
6 |
국립보건원 방역과, 결핵연구원. 2001년도 국가결핵관리사업 평가. 2001
|
7 |
Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for na-tional programmes. 2nd ed. 1997. World Heal-th Organization, Geneva, Switzerland, WHO/TB/97.220
|
8 |
Farmer P. Managerial successes, clinical failures. Int J Tuberc Lung Dis 1999;3:365-7
|
9 |
Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization(Leading article). Tubercle 1991;72:1-6
|
10 |
Akkslip S, Rasmithat S, Maher D, Sawert H. Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand. Int J Tuberc Lung Dis 1999;3(12):1061-5
|
11 |
Zalesky R, Abdullajev F, Khechinashvili G, et al. Tuberculosis control in the Caucasus:successes and constraints in DOTS imple-mentation. Int J Tuberc Lung Dis 1999;3(5):394-401
|
12 |
World Health Organization. An Expanded DOTS Framework for effective Tuberculosis Control. WHO/CDS/TB/2002.297. 2002
|
13 |
Lambregts-van Weezenbek KSB, Reichman LB. DOTS and DOTS-Plus : what's in a name. Int J Tuberc Lung Dis 2000;4(11):995-6
|
14 |
Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse of tuber-culosis. N Engl J Med 1994;330:1179-84
|
15 |
Farmer P, Kim JY, Mitnick C, Timperi R. Responding to outbreaks of multidrug-resi-stant tuberculosis--introducing DOTS PLUS. In: Reichman LB, Hershfield E. Tuberculosis: a comprehensive international approach. 2nd ed. New York: Marcel Dekker Inc., 2000. In Press
|
16 |
서울특별시. 2001년 결핵사업관리평가서. 2002
|
17 |
SAS, SAS proprietary software release 8.1.Cary, NC: SAS institute, Inc., USA
|
18 |
Rieder HL. Sputum smear conversion during directly observed treatment for tuberculosis. Tubercle Lung Dis 1996;77:124-9
|
19 |
Balasubramanian VN, Oommen K, Samuel R. DOT or not? Direct observation of anti-tu-berculosis treatment and patient outcomes, Kerala State, India. Int J Tuberc Lung Dis 2000;4(5):409-13
|
20 |
Gordis L. Epidemiology. 2nd ed. WB Saun-ders Co.; 2000. p. 148-149
|
21 |
홍영표. 우리나라 결핵관리. 건강보장연구 1999;3:111-48
|
22 |
World Health Organization. Tuberculosis: a global emergency(WHO Notes & News). World Health Forum 1993;14:438
|
23 |
Hurtig AK, Porter JDH, Ogden JA. Tuber-culosis control and directly observed therapy from the public health/human rights perspec-tive. Int J Tuberc Lung Dis 1999;3:553-60
|